Immunotherapeutic Vaccines investors in the United States.

Immunotherapeutic Vaccines investors in the United States

Fliar publishes 1 investor page for Immunotherapeutic Vaccines in the United States. That is 1 investor list. The list with the most capital behind it is Immunotherapeutic Vaccines investors in Cambridge ($6.7B across the rounds it covers).

This is the only one we publish so far. For a wider view, see all Immunotherapeutic Vaccines investor pages or everything in the United States.

Close neighbours of Immunotherapeutic Vaccines are Gastroenterology, Gene Editing, Chemicals Tech, Rare Metabolic Diseases Drugs, Microbiome Therapeutics and AI Drug Discovery.